MX2009009557A - Formulaciones de aposito para prevenir o reducir la cicatrizacion. - Google Patents

Formulaciones de aposito para prevenir o reducir la cicatrizacion.

Info

Publication number
MX2009009557A
MX2009009557A MX2009009557A MX2009009557A MX2009009557A MX 2009009557 A MX2009009557 A MX 2009009557A MX 2009009557 A MX2009009557 A MX 2009009557A MX 2009009557 A MX2009009557 A MX 2009009557A MX 2009009557 A MX2009009557 A MX 2009009557A
Authority
MX
Mexico
Prior art keywords
prevent
dressing formulations
reduce scarring
formulation
silicone elastomer
Prior art date
Application number
MX2009009557A
Other languages
English (en)
Inventor
Brian C Keller
Original Assignee
Crescendo Therapeutics Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Crescendo Therapeutics Llc filed Critical Crescendo Therapeutics Llc
Publication of MX2009009557A publication Critical patent/MX2009009557A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/58—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing atoms other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur or phosphorus
    • A61K8/585—Organosilicon compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/89—Polysiloxanes
    • A61K8/895—Polysiloxanes containing silicon bound to unsaturated aliphatic groups, e.g. vinyl dimethicone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/26—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0019—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/0066—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/62—Encapsulated active agents, e.g. emulsified droplets
    • A61L2300/626—Liposomes, micelles, vesicles

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Se proporciona en la presente una formulación de apósito de cicatrización que comprende una mezcla de un polímero cruzado de elastómero de silicona de alto peso molecular y un aceite de silicona, en donde el polímero cruzado de elastómero de silicona está en un fluido volátil. La formulación tiene una sensación sedosa, suave, sin ser grasosa y se seca rápidamente para formar un apósito de cicatrización flexible, durable.
MX2009009557A 2007-03-08 2008-03-10 Formulaciones de aposito para prevenir o reducir la cicatrizacion. MX2009009557A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US90598407P 2007-03-08 2007-03-08
PCT/US2008/056443 WO2008109887A1 (en) 2007-03-08 2008-03-10 Dressing formulations to prevent and reduce scarring

Publications (1)

Publication Number Publication Date
MX2009009557A true MX2009009557A (es) 2010-08-10

Family

ID=39738850

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009009557A MX2009009557A (es) 2007-03-08 2008-03-10 Formulaciones de aposito para prevenir o reducir la cicatrizacion.

Country Status (10)

Country Link
US (3) US20100196454A1 (es)
EP (1) EP2120823A4 (es)
JP (1) JP5523114B2 (es)
CN (2) CN103480026A (es)
AU (1) AU2008222638B2 (es)
BR (1) BRPI0808660A2 (es)
CA (1) CA2680279A1 (es)
CO (1) CO6220896A2 (es)
MX (1) MX2009009557A (es)
WO (1) WO2008109887A1 (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100322875A1 (en) 2009-06-18 2010-12-23 Advanced Bio-Technologies, Inc. Silicone scar treatment preparation
MX2012000434A (es) * 2009-07-09 2012-04-11 Crescendo Therapeutics Llc Metodo de sanacion de herida y modulacion de cicatriz.
GB201108229D0 (en) 2011-05-17 2011-06-29 Smith & Nephew Tissue healing
US20140357729A1 (en) * 2011-12-21 2014-12-04 Maruho Co., Ltd. Topical composition containing silicone base
WO2014019840A2 (en) * 2012-08-01 2014-02-06 Dow Corning Corporation Aqueous silicone dispersions and their preparation
CN103341216B (zh) * 2013-06-04 2014-12-10 青岛中腾生物技术有限公司 一种祛疤修复材料及其制备方法
US9814774B2 (en) * 2013-08-12 2017-11-14 Nycfs, Llc Dermatological product
US9511034B1 (en) 2013-12-09 2016-12-06 Bio-Silicote, Inc. Method for applying a skin treatment
US9226890B1 (en) 2013-12-10 2016-01-05 Englewood Lab, Llc Polysilicone base for scar treatment
DE102014213155A1 (de) * 2014-07-07 2016-01-07 Henkel Ag & Co. Kgaa Silikongel mit trockener Haptik
CN104814886A (zh) * 2015-04-10 2015-08-05 浙江省诸暨市珠力神医用品有限公司 一种硅凝胶组合物
US20170202877A1 (en) * 2016-01-19 2017-07-20 Reoxcyn Discoveries Group, Inc. Hypochlorite formulations for wound healing
TWI615159B (zh) * 2017-07-07 2018-02-21 泰陞國際科技股份有限公司 液體皮膚保護組合物
KR20190013101A (ko) * 2017-07-31 2019-02-11 이호석 흉터의 예방 또는 치료를 위한 조성물
KR102113317B1 (ko) * 2019-10-04 2020-05-20 이호석 흉터의 예방 또는 치료를 위한 조성물
CN110859989B (zh) * 2019-10-25 2021-06-22 天津冠勤医药科技有限公司 一种液体创可贴及其制备方法
CN111035801B (zh) * 2020-01-14 2022-01-14 青岛科技大学 银纳米团簇基壳聚糖水凝胶敷料及其制备方法和应用
CN111228560B (zh) * 2020-01-14 2021-09-21 华南理工大学 一种基于离子氢键的双层聚硅氧烷超分子弹性体敷料及其制备方法
KR102205025B1 (ko) * 2020-05-13 2021-01-19 이호석 흉터의 예방 또는 치료를 위한 조성물
CN115463243B (zh) * 2022-08-18 2023-09-15 南通大学 一种抑制疤痕增生的纳米敷料及其制备方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0076068A3 (en) * 1981-09-25 1985-05-15 Beecham Group Plc Intramammary veterinary compositions and method for their use
FR2581548B1 (fr) * 1985-05-09 1990-07-20 Villette Alain Dispositif d'injection intraosseuse de produits biocompatibles
GB8720799D0 (en) * 1987-09-04 1987-10-14 Biocompatibles Ltd Dressing
US5013769A (en) * 1988-08-22 1991-05-07 Medipro Sciences Limited Method of making a hydrogel-forming wound dressing or skin coating material
US4987893A (en) * 1988-10-12 1991-01-29 Rochal Industries, Inc. Conformable bandage and coating material
KR930004567B1 (ko) * 1988-12-09 1993-06-01 보르크 바르너 오토모티브 게엠베하 마찰 라이닝 지지판과 허브를 결합시키는 스프링 콜릿을 갖는 마찰요소
US5302382A (en) * 1993-06-03 1994-04-12 Dow Corning Corporation Silicone containing personal care products
US5998542A (en) * 1997-12-12 1999-12-07 General Electric Company Processing of an elastomer dispersion
AU2001256347A1 (en) * 2000-05-23 2001-12-03 Unilever Plc Deodorant and/or antiperspirant compositions
US6610322B1 (en) * 2000-12-20 2003-08-26 Brian Charles Keller Self forming, thermodynamically stable liposomes and their applications
US6998421B2 (en) * 2001-06-07 2006-02-14 Biozone Laboratories, Inc. Compounds and methods for inhibition of phospholipase A2 and cyclooxygenase - 2
US6495596B1 (en) * 2001-03-23 2002-12-17 Biozibe Laboratories, Inc. Compounds and methods for inhibition of phospholipase A2 and cyclooxygenase-2
US6838078B2 (en) * 2002-01-16 2005-01-04 3M Innovative Properties Company Film-forming compositions and methods
US20030180281A1 (en) * 2002-03-11 2003-09-25 Bott Richard R. Preparations for topical skin use and treatment
GB0216427D0 (en) * 2002-07-16 2002-08-21 Advanced Biotechnologies Inter Wound dressing
US20050014729A1 (en) * 2003-07-16 2005-01-20 Pharmacia Corporation Method for the treatment or prevention of dermatological disorders with a cyclooxygenase-2 inhibitor alone and in combination with a dermatological treatment agent and compositions therewith
US7300649B2 (en) * 2005-02-11 2007-11-27 Genepharm, Inc. Cosmetic and cosmeceutical compositions for restoration of skin barrier function
RU2008100037A (ru) * 2005-06-10 2009-07-20 Галдерма С.А. (Ch) Способ регулируемого высвобождения лекарственного средства через кожу
US20080317830A1 (en) * 2007-06-25 2008-12-25 Liolabs Llc Compositions and Methods for the Treatment of Wounds and Scar Tissue

Also Published As

Publication number Publication date
US20180221689A1 (en) 2018-08-09
JP2010520890A (ja) 2010-06-17
CN101742979B (zh) 2013-07-17
EP2120823A1 (en) 2009-11-25
CA2680279A1 (en) 2008-09-12
CO6220896A2 (es) 2010-11-19
EP2120823A4 (en) 2012-11-28
AU2008222638A1 (en) 2008-09-12
AU2008222638B2 (en) 2013-10-31
WO2008109887A1 (en) 2008-09-12
CN103480026A (zh) 2014-01-01
US20170368378A1 (en) 2017-12-28
BRPI0808660A2 (pt) 2014-08-19
JP5523114B2 (ja) 2014-06-18
CN101742979A (zh) 2010-06-16
US20100196454A1 (en) 2010-08-05

Similar Documents

Publication Publication Date Title
MX2009009557A (es) Formulaciones de aposito para prevenir o reducir la cicatrizacion.
ATE484539T1 (de) Polysiloxan-/polyimid-copolymermischungen
ES2543469T3 (es) Cosmético para la piel en emulsión de tipo agua en aceite
MXPA06010767A (es) Composicion farmaceutica anhidra que asocia un agente siliconado y principio activo solubilizado.
GB2430157A (en) Personal care products and methods for inhibiting the adherence of flora to skin
WO2007101059A3 (en) Polymers containing silicone copolyol macromers and personal care compositions containing same
CL2008000915A1 (es) Compuestos triciclicos moduladores de 11beta-hidroxiesteroidedeshidrogenasa tipo 1; y uso en el tratamiento, prevencion y/o profilaxis de enfermedades tales como sindrome metabolico, resistencia a la insulina, dislipidemia, hipertension y obesidad.
ECSP11011459A (es) Composiciones sublinguales de dexmedetomidina y métodos de uso de ellas
BR112014018688A8 (pt) Aplicador médico de antisséptico
UA98960C2 (uk) Пінні композиції, що не містять поверхнево-активних речовин
MX2009004332A (es) Formulaciones de liberacion sostenida que comprenden polimeros de peso molecular muy bajo.
WO2009074735A3 (fr) Utilisation d'un nouvel agent naturel dans des compositions cosmetiques
WO2010104186A3 (en) Oil-in-water silicone emulsion composition
FR2930554B1 (fr) Melange elastomerique comprenant majoritairement un elastomere dienique couple par un groupe amino-alcoxysilane, composition de caoutchouc le comprenant et leurs procedes d'obtention.
CR8602A (es) Composiciones y metodos para aplicacion topica y suministro transdermico de toxinas botulinum
CL2009001874A1 (es) Uso de bacillus subtilis qst713 nrrl b-21661 para formular una composición probiótica para un animal; y composición probiotica de bacillus subtilis qst713 nrrl b-21661.
MX2010004262A (es) Formulaciones topicas de glicopirrolato.
EA200701029A1 (ru) Новая композиция для облегчения человеческих родов
UA100507C2 (ru) Предупреждение и лечение субклинической формы болезней, вызываемых цирковирусом свиней (pcvd)
WO2010062581A3 (en) A botanical composition for enhanced skin repair and uses thereof
FR2964565B1 (fr) Composition cosmetique comprenant un polymere fixant et un agent antipelliculaire
SG171625A1 (en) Antiseptic-containing silicone elastomers
WO2011019718A3 (en) Personal care composition with improved spreadability
WO2009031099A3 (en) Cosmetic use of microorganisms
CL2009000660A1 (es) Uso de un antagonista del receptor 2 activado con proteasa (par2) para tratar, inhibir o aliviar el dolor.

Legal Events

Date Code Title Description
HC Change of company name or juridical status

Owner name: CHILDREN S MEDICAL CENTER CORPORATION

FG Grant or registration